Terms: = Colorectal cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Clinical Outcome
3 results:
1. Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.
Eppenberger M; Zlobec I; Baumhoer D; Terracciano L; Lugli A
BMC Cancer; 2010 Mar; 10():93. PubMed ID: 20222950
[TBL] [Abstract] [Full Text] [Related]
2. The oncologic benefit of high ligation of the inferior mesenteric artery in the surgical treatment of rectal or sigmoid colon cancer.
Chin CC; Yeh CY; Tang R; Changchien CR; Huang WS; Wang JY
Int J Colorectal Dis; 2008 Aug; 23(8):783-8. PubMed ID: 18438677
[TBL] [Abstract] [Full Text] [Related]
3. Reciprocal regulation of rhoa and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma.
Bellovin DI; Simpson KJ; Danilov T; Maynard E; Rimm DL; Oettgen P; Mercurio AM
Oncogene; 2006 Nov; 25(52):6959-67. PubMed ID: 16715134
[TBL] [Abstract] [Full Text] [Related]